MX2022006677A - Composiciones esteticas de peso molecular alto. - Google Patents

Composiciones esteticas de peso molecular alto.

Info

Publication number
MX2022006677A
MX2022006677A MX2022006677A MX2022006677A MX2022006677A MX 2022006677 A MX2022006677 A MX 2022006677A MX 2022006677 A MX2022006677 A MX 2022006677A MX 2022006677 A MX2022006677 A MX 2022006677A MX 2022006677 A MX2022006677 A MX 2022006677A
Authority
MX
Mexico
Prior art keywords
molecular weight
high molecular
compositions
esthetic
gag
Prior art date
Application number
MX2022006677A
Other languages
English (en)
Inventor
Morgan Karlsson
Johan Olsson
Original Assignee
Galderma Holding SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Holding SA filed Critical Galderma Holding SA
Publication of MX2022006677A publication Critical patent/MX2022006677A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/17—Amines; Quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Se describen composiciones de hidrogel de glicosaminoglicanos (GAG) de alto peso molecular, que comprenden GAG reticulados de forma covalente con un reticulante de carbohidrato, y métodos para preparar las composiciones de hidrogel de GAG de alto peso molecular. Además, se describen métodos de uso de las composiciones de hidrogel de glicosaminoglicanos (GAG) de alto peso molecular para cirugía plástica o reparadora, dermatología estética, contorno facial, contorno corporal y aumento gingival.
MX2022006677A 2019-12-02 2020-12-01 Composiciones esteticas de peso molecular alto. MX2022006677A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962942624P 2019-12-02 2019-12-02
PCT/IB2020/061336 WO2021111303A1 (en) 2019-12-02 2020-12-01 High molecular weight esthetic compositions

Publications (1)

Publication Number Publication Date
MX2022006677A true MX2022006677A (es) 2022-07-27

Family

ID=73740452

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022006677A MX2022006677A (es) 2019-12-02 2020-12-01 Composiciones esteticas de peso molecular alto.

Country Status (14)

Country Link
US (2) US11730691B2 (es)
EP (1) EP4069753A1 (es)
JP (1) JP2023504528A (es)
KR (1) KR20220110786A (es)
CN (1) CN115335414B (es)
AR (1) AR122343A1 (es)
AU (1) AU2020395955A1 (es)
BR (1) BR112022010831A2 (es)
CA (1) CA3160575A1 (es)
IL (1) IL293540A (es)
MX (1) MX2022006677A (es)
TW (1) TW202128127A (es)
WO (1) WO2021111303A1 (es)
ZA (1) ZA202206990B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114539636A (zh) * 2022-02-16 2022-05-27 成都微沃科技有限公司 一种具有粘弹性的海藻酸-壳聚糖生物惰性水凝胶

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3684887D1 (de) 1985-11-29 1992-05-21 Biomatrix Inc Arzneistoffabgabesysteme auf basis von hyaluronan, dessen derivaten und salzen sowie verfahren zu deren herstellung.
JPS62265998A (ja) 1986-03-10 1987-11-18 ボ−ド　オブ　リ−ジエンツ　ザ　ユニヴア−シテイ　オブ　テキサス　システム ヘパラン硫酸エンドグリコシダーゼアッセイ
US4859581A (en) 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
DE4200080A1 (de) 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
DE4439575A1 (de) 1994-11-05 1996-05-09 Permselect Ges Fuer Zellstrukt Neue Vernetzungsprodukte auf Basis Hyaluronsäure
WO1997011958A1 (en) 1995-09-29 1997-04-03 The Scripps Research Institute Protein signature analysis
FR2764514B1 (fr) 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
JP4385152B2 (ja) 1997-09-17 2009-12-16 三菱化学株式会社 ２価反応性水溶性高分子誘導体及びそれを含有する複合体
KR19990029749A (ko) 1997-09-17 1999-04-26 미우라 아끼라 2가 반응성 수용성 고분자 유도체 및 이들을 함유하는 복합체
FR2777193B1 (fr) 1998-04-14 2001-06-08 Coletica Particule a groupement hydroxamique chelatante d'ions metalliques et leur utilisation en cosmetique ou en pharmacie
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US6630457B1 (en) 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
IT1303735B1 (it) 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
GB9902412D0 (en) 1999-02-03 1999-03-24 Fermentech Med Ltd Process
GB9902652D0 (en) 1999-02-05 1999-03-31 Fermentech Med Ltd Process
IT1317358B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
KR100375299B1 (ko) 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
EP1448991A2 (en) 2001-04-09 2004-08-25 Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.V. Activated enzyme-linked detection systems for detecting and quantifying nucleid acids, antigens, antibodies and other analytes
EP1409728A2 (en) 2001-04-09 2004-04-21 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Non-enzymatic liposome-linked closely spaced array electrodes assay (nel-ela) for detecting and quantifying nucleic acids
FR2826657B1 (fr) 2001-06-29 2003-09-05 Rhodia Chimie Sa Polymeres derives de polysaccharides comprenant une ou plusieurs fonctions oxime ou amine et utilisations desdits polymeres
US7314636B2 (en) 2001-06-29 2008-01-01 Medgraft Microtech, Inc. Biodegradable injectable implants containing glycolic acid
US8524884B2 (en) 2001-10-30 2013-09-03 Colorado State University Research Foundation Outer layer material having entanglement of hydrophobic polymer hostblended with a maleated hydrophobic polymer co-host, and hydrophilic polymer guest
KR20040009891A (ko) 2002-07-26 2004-01-31 주식회사 엘지생명과학 히알루론산의 유도체 겔 및 그 제조방법
PT102888B (pt) 2002-12-23 2005-04-29 Filipe Manuel Rodrigues Aguiar Processo industrial de producao de acido polilactico (pla) obtido por esterificacao e polimerizacao de acido lactico purificado, sendo o referido acido produzido atraves de um processo fermentativo
TWI251596B (en) 2002-12-31 2006-03-21 Ind Tech Res Inst Method for producing a double-crosslinked hyaluronate material
US7115388B2 (en) 2003-03-14 2006-10-03 National Institute Of Agrobiological Sciences Production of functional polypeptides originating from silk protein and use thereof
US20160106717A1 (en) 2004-09-24 2016-04-21 Gen Pharma Holdings LLC Cai-based systems and methods for the localized treatment of uveitis
DE102005055385A1 (de) 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
CA2620663A1 (en) 2005-09-02 2007-03-08 Colbar Lifescience Ltd. Cross-linked polysaccharide and protein matrices and methods for their preparation
CN101309709A (zh) 2005-09-21 2008-11-19 苏尔莫迪克斯公司 包含天然生物可降解的多糖的涂层和物品
DE102006013594A1 (de) 2006-03-22 2007-09-27 Biopolymer Gmbh & Co. Kg Quervernetzte Gele von Hyaluronsäure und deren Verwendung
ITRM20080636A1 (it) 2008-11-28 2010-05-29 Univ Palermo Procedimento per la produzione di derivati funzionalizzati dell acido ialuronico e relativi idrogeli.
WO2010065784A2 (en) 2008-12-03 2010-06-10 Jakk Group, Inc. Methods, devices, and compositions for dermal filling
US10105197B1 (en) 2009-03-26 2018-10-23 Fernando Colon Method of treatment for periodontal pockets
AU2010232547A1 (en) 2009-04-02 2011-10-27 Allergan, Inc. Hair-like shaped hydrogels for soft tissue augmentation
KR101831918B1 (ko) 2010-06-11 2018-02-27 한국원자력의학원 히알루론산의 탈아세틸화 가수분해효소, 및 이에 의해 탈아세틸화된 히알루론산 및 이의 유도체
KR101834588B1 (ko) 2010-08-23 2018-03-05 덴카 주식회사 가교 히알루론산 조성물 및 자기 가교 히알루론산 입자
JP6141180B2 (ja) 2011-03-03 2017-06-07 中外製薬株式会社 アミノ−カルボン酸により修飾されたヒアルロン酸誘導体
US9649385B2 (en) 2011-09-07 2017-05-16 Prolynx Llc Hydrogels with biodegradable crosslinking
PL3175840T3 (pl) 2011-12-08 2021-01-25 Allergan Industrie, Sas Kompozycje wypełniacza skórnego
US8887243B2 (en) 2012-01-30 2014-11-11 Cisco Technology, Inc. Integrated security platform
CN102952281B (zh) 2012-09-13 2014-03-19 江苏隆源生物科技有限公司 一种壳寡糖和透明质酸交联凝胶的制备方法
EP2727597A1 (en) 2012-11-06 2014-05-07 Centre National de la Recherche Scientifique (CNRS) Glucose responsive hydrogel comprising pba-grafted hyaluronic acid (ha)
CN103087333B (zh) * 2012-11-13 2014-08-06 西安交通大学 一种可快速解离型温敏性透明质酸水凝胶的制备方法
WO2015005345A1 (ja) 2013-07-08 2015-01-15 電気化学工業株式会社 コアシェル型架橋ヒアルロン酸ゲル粒子、その製造方法及び医用材料
CA2919088A1 (en) 2013-08-07 2015-02-12 Arrowhead Research Corporation Polyconjugates for delivery of rnai triggers to tumor cells in vivo
WO2015034436A1 (en) 2013-09-03 2015-03-12 Agency For Science, Technology And Research Polymer-flavonoid conjugates and hydrogels for biomedical applications
CN103788222B (zh) 2014-01-08 2016-08-31 中国科学院昆明植物研究所 Fuc3S4S取代的低聚糖胺聚糖及其制备方法
MX367853B (es) 2014-05-29 2019-09-09 Galderma Sa Ácido hialurónico entrelazado injertado con dextrán.
WO2015181365A1 (en) 2014-05-29 2015-12-03 Galderma S.A. Cyclodextrin-grafted hyaluronic acid crosslinked with dextran and uses thereof
CN104194066B (zh) 2014-09-15 2016-08-24 中国科学院上海硅酸盐研究所 氧化硅-壳聚糖复合气凝胶及其制备方法
BR112018013523B1 (pt) 2015-12-29 2022-06-14 Galderma S.A. Produto de hidrogel compreendendo moléculas de glicosaminoglicano reticuladas e processo para preparação de um produto de hidrogel
WO2019002370A1 (en) * 2017-06-28 2019-01-03 Nestlé Skin Health Sa GLYCOSAMINOGLYCANES RETICULATED AND FUNCTIONALIZED
WO2019002368A1 (en) * 2017-06-28 2019-01-03 Nestlé Skin Health Sa GLYCOSAMINOGLYCANES RETICULATED AND FUNCTIONALIZED
WO2019001784A1 (en) * 2017-06-28 2019-01-03 Nestlé Skin Health Sa HYALURONIC ACID GEL WITH A DIVALENT CATION
CN108465128B (zh) * 2018-03-01 2021-03-16 杭州协合医疗用品有限公司 一种交联透明质酸细胞支架材料的制备方法

Also Published As

Publication number Publication date
BR112022010831A2 (pt) 2022-08-23
WO2021111303A1 (en) 2021-06-10
ZA202206990B (en) 2024-01-31
JP2023504528A (ja) 2023-02-03
CN115335414B (zh) 2024-03-19
CN115335414A (zh) 2022-11-11
US11730691B2 (en) 2023-08-22
US20230346680A1 (en) 2023-11-02
TW202128127A (zh) 2021-08-01
CA3160575A1 (en) 2021-06-10
KR20220110786A (ko) 2022-08-09
AU2020395955A1 (en) 2022-07-14
AR122343A1 (es) 2022-09-07
IL293540A (en) 2022-08-01
EP4069753A1 (en) 2022-10-12
US20210161796A1 (en) 2021-06-03

Similar Documents

Publication Publication Date Title
WO2018212792A3 (en) BIOPOLYMER COMPOSITIONS, SCAFFOLDING AND DEVICES
EP3269328A3 (en) Cardiac valve implant
WO2018054542A3 (en) Macroscopically alignable, injectable, soft hydrogel composition
MY186349A (en) Oral care compositions and methods of use
WO2008147817A3 (en) Coated hyaluronic acid particles
BR112015022161A2 (pt) implante intraocular contendo prostamida
MX344236B (es) Hidrolizado de colageno para usarse para mejorar la salud de la piel, el cabello y/o uñas de un humano.
UA95660C2 (ru) Имплантат, который инъектируется, для защиты дермы от свободных радикалов, набор в форме шприца, который содержит такой имплантат, применение гиалуроновой кислоты для изготовления имплантата, способ получения и применения имплантата, косметический способ заполнения морщин и/или мелких морщин
MX2010001219A (es) Composiciones de acido hialuronico ajustablemente reticuladas.
MX2014004458A (es) Hebra de acido hialuronico reticulado y metodos de uso de las mismas.
MX2021003552A (es) Dispositivos implantables para terapia celular y metodos relacionados.
ZA202206990B (en) High molecular weight esthetic compositions
AR107967A1 (es) Ácido hialurónico modificado, método para su preparación y usos del mismo
PH12020550032A1 (en) Gel comprising chlorhexidine
EA202193053A1 (ru) Хитозан и его применения
MX2019009711A (es) Mejoras en o con respecto a compuestos organicos.
BR112022004397A2 (pt) Composições para tratamento bucal que compreendem beta ácidos de lúpulo e aminoácidos
MX2018007048A (es) Composiciones para el cuidado bucal que comprenden al menos un copolimero de fosfato / acrilato y al menos un ingrediente activo cationico.
DE602004022996D1 (de) Kosmetische zusammensetzung mit einem ampholyt-copolymer
MX2019003206A (es) Gel de acido hialuronico con un cation de zinc divalente.
BR112022025845A2 (pt) Composição biocompatível, preenchimento de tecidos e método de tratamento ou prevenção de um distúrbio, doença ou condição
HRP20210574T1 (hr) Hitozan s neionskim nabojem
EP4252776A3 (en) Compositions and methods for treating ocular diseases
BR112022002624A2 (pt) Unidade tridimensional oca feita a partir de tecido retiniano e uso da mesma no tratamento de retinopatias
MX2022010093A (es) Tafoxiparina para el tratamiento de la preeclampsia.